Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Parikh

Showing results (251-260 of 385) with videos related to

Pageof 39
Sort By:
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Systems-based improvement in door-to-balloon times at a large urban teaching hospital: a follow-up study from Parkland Health and Hospital SystemShailja V Parikh, D Brent Treichler, Sheila DePaola, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]Sagar V Parikh, Ari Zaretsky, Serge Beaulieu, et al.
The Journal of Biological Chemistry|September 5, 2020
SOX9 promotes stress-responsive transcription of VGF nerve growth factor inducible gene in renal tubular epithelial cellsJi Young Kim, Yuntao Bai, Laura A Jayne, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scaleRoger S McIntyre, Jakub Z Konarski, Deborah A Mancini, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological TreatmentsSagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
Kidney International Reports|March 20, 2023
The Diagnostic Conundrum of Glomerular Crescents With IgA DepositsMineaki Kitamura, Salem Almaani, Bindu Challa, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
The Journal of Clinical Psychiatry|May 8, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part II: AssessmentJay C Fournier, Vitaliy L Voytenko, Anna R Docherty, et al.
Pageof 39

Showing results (251-260 of 385) with videos related to

Sort By:
Pageof 39
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
Systems-based improvement in door-to-balloon times at a large urban teaching hospital: a follow-up study from Parkland Health and Hospital SystemShailja V Parikh, D Brent Treichler, Sheila DePaola, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]Sagar V Parikh, Ari Zaretsky, Serge Beaulieu, et al.
The Journal of Biological Chemistry|September 5, 2020
SOX9 promotes stress-responsive transcription of VGF nerve growth factor inducible gene in renal tubular epithelial cellsJi Young Kim, Yuntao Bai, Laura A Jayne, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 24, 2023
Efficacy and safety of zuranolone co-initiated with an antidepressant in adults with major depressive disorder: results from the phase 3 CORAL studySagar V Parikh, Scott T Aaronson, Sanjay J Mathew, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|November 23, 2005
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scaleRoger S McIntyre, Jakub Z Konarski, Deborah A Mancini, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|August 4, 2016
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological TreatmentsSagar V Parikh, Lena C Quilty, Paula Ravitz, et al.
Psychiatry Research|May 10, 2023
The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 reportManish Dama, Michelle Wu, Vanessa K Tassone, et al.
Kidney International Reports|March 20, 2023
The Diagnostic Conundrum of Glomerular Crescents With IgA DepositsMineaki Kitamura, Salem Almaani, Bindu Challa, et al.
The Journal of ECT|September 14, 2021
Electroconvulsive Therapy in Canada During the First Wave of COVID-19: Results of the "What Happened" National SurveyIlya Demchenko, Daniel M Blumberger, Alastair J Flint, et al.
The Journal of Clinical Psychiatry|May 8, 2025
Developing a Treatment-Resistant Depression Consultation Program, Part II: AssessmentJay C Fournier, Vitaliy L Voytenko, Anna R Docherty, et al.
Pageof 39